Clinical Trial Update: Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high-dose letrozole therapy in postmenopausal women with advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Postmenopausal Women With Advanced Breast Cancer | Phase 2 | Status: COMPLETED